Gut microbiome, enteric infections and child growth across a rurual urban gradient
农村城市梯度中的肠道微生物组、肠道感染和儿童生长
基本信息
- 批准号:10432022
- 负责人:
- 金额:$ 134.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-24 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute DiarrheaAffectAnimalsAntibioticsAreaBehavioral GeneticsBirthCharacteristicsChildChild HealthChronicCognitive deficitsCohort StudiesCommunitiesComplementDataDevelopmentDiagnosticDiarrheaDietDiseaseEcuadorEnteralEnvironmental ExposureEpidemiologyFunctional disorderGenomicsGrowthHealthHouseholdHumanHygieneImmune responseImmune systemImmunologyImpairmentIncidenceIndividualInfantInfant DevelopmentInfectionLaboratoriesLatin AmericaLeadLifeLocationMetagenomicsMorbidity - disease rateNewborn InfantNutritional statusOutcomePatternPhasePlayPopulationPopulation HeterogeneityRaceResearchRoleRuralSanitationSiteSystems DevelopmentTechniquesTestingTherapeuticTimeWaterWorkacute infectionacute symptomassociated symptombasedesignenteric infectionenteric pathogenenvironmental interventionexperiencefeedinggut healthgut microbiomegut microbiotaimprovedinfant gut microbiomeinsightinterestmicrobialmicrobiomemicrobiome compositionmicrobiome signaturenutritionpathogenresponsesocialstudy populationtherapy designtherapy developmenttransmission process
项目摘要
Enteropathogen infections in the first two years of life—with or without acute symptoms—are associated with
serious morbidities, including diarrhea, gut impairment, growth faltering, and cognitive deficits. A critical current
question in the field of enteric diseases research is why some enteric infections are symptomatic and some are
asymptomatic. Characteristics of the infant gut microbiome may influence the course of enteric infections, but
the implications of microbiome-enteropathogen interactions are not well understood. Increasing data suggests
that cumulative enteropathogen infections early in life, even when asymptomatic for diarrhea, are associated
with chronic gut conditions, such as environmental enteric dysfunction (EED), that influence child health. In this
study, we will test the hypothesis that gut microbiome characteristics are associated with differential
responses to enteropathogen infections for acute and chronic child health outcomes by carrying out a
community-based birth cohort study of 360 newborn infants from three sites along a rural-urban gradient in
northern coastal Ecuador. This setting provides an ideal location to examine interactions between the gut
microbiome conditions and enteric infections, because we leverage a population where our team has worked
for 15 years that is a high enteric pathogen transmission setting with known variability in gut microbiome
characteristics yet relative similarity in other social, behavioral and genetic factors that might determine host
response to enteric infections. We will use state-of the-art diagnostic and genomic techniques to characterize
enteropathogen infections and gut microbial communities at multiple time points over their first two years of life,
controlling for other factors related to delivery mode, diet, and nutritional status that are known to be
associated with gut conditions. Through this approach, we will isolate the effects of the gut microbiome on the
health impacts of enteropathogen infection. The differences in microbiome diversity that we have previously
observed between urban and rural sites also provides the opportunity to examine the environmental
determinants of gut microbiome composition and development in infants. Our specific aims (SAs) are designed
to provide important insights into: SA1) how environmental conditions affect the developing infant gut
microbiome and pathobiome; SA2) whether the infant gut microbiome modifies the acute (diarrhea) and
chronic (EED and growth faltering) outcomes of enteric pathogen infection; and SA3) how the gut microbiome
responds and recovers from enteric pathogen infection. This project moves beyond the discovery phase of gut
microbiome studies by concurrently studying gut microbiome and health outcomes to gain insights into
functional implications of gut microbiome conditions. The results will guide environmental interventions and
development of preventative and therapeutic approaches to improve child health outcomes, and will provide
information to identify the signatures of symptomatic and asymptomatic infections in microbial communities of
the gut.
在生命的头两年(随着急性症状或没有急性症状),肠病的感染与
严重的病态,包括腹泻,肠道损害,伪造和认知缺陷。关键电流
肠道疾病研究领域的问题是为什么某些肠道感染是有症状的,有些是有症状的
无症状。婴儿肠道微生物组的特征可能会影响肠道感染的过程,但
微生物组 - 肠病相互作用的含义尚不清楚。越来越多的数据表明
即使腹泻不对称的累积性肠病感染也是如此
在慢性肠道条件下,例如环保肠功能障碍(EED),会影响儿童健康。在这个
研究,我们将测试肠道微生物组特征与差异相关的假设
对急性和慢性儿童健康结果的肠病感染的反应
基于社区的出生队列研究,对来自三个地点的360名新生婴儿沿着粗糙城市的梯度进行
北部厄瓜多尔。此设置提供了检查肠道之间相互作用的理想位置
微生物组的条件和促进者,因为我们利用团队工作的人口
15年来,这是一个高促进病原体传播设置,肠道微生物组已知可变性
特征但可能决定宿主的其他社会,行为和遗传因素的相对相似性
促进感染的反应。我们将使用最先进的诊断和基因组技术来表征
在生命的头两年,肠病的感染和肠道微生物群落在多个时间点,
控制与交货模式,饮食和营养状况有关的其他因素
与肠道条件相关。通过这种方法,我们将隔离肠道微生物组对
肠病感染的健康影响。我们以前拥有的微生物组多样性的差异
在城市和粗糙的遗址之间观察到的也提供了检查环境的机会
肠道微生物组组成和婴儿发育的决定因素。我们的具体目标(SAS)是设计的
提供重要的见解:SA1)环境条件如何影响发育中的婴儿肠道
微生物组和病原体; SA2)婴儿肠道微生物组是否修饰急性(腹泻)和
肠道病原体感染的慢性(EED和生长伪造)结局; SA3)肠道微生物组如何
从肠道病原体感染中反应并恢复。该项目超越了肠道发现阶段
微生物组研究通过同时研究肠道微生物组和健康结果,以了解
肠道微生物组条件的功能意义。结果将指导环境干预措施和
开发预防和治疗方法以改善儿童健康结果,并将提供
信息以识别微生物群落中症状和不对称感染的特征
肠道。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph N. S. Eisenberg其他文献
Joseph N. S. Eisenberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph N. S. Eisenberg', 18)}}的其他基金
Zoonotic Uropathogenic Escherichia coli in Northwest Ecuador: Incidence and Risk Factors
厄瓜多尔西北部人畜共患泌尿道致病性大肠杆菌:发病率和危险因素
- 批准号:
10417979 - 财政年份:2022
- 资助金额:
$ 134.82万 - 项目类别:
Zoonotic Uropathogenic Escherichia coli in Northwest Ecuador: Incidence and Risk Factors
厄瓜多尔西北部人畜共患泌尿道致病性大肠杆菌:发病率和危险因素
- 批准号:
10661031 - 财政年份:2022
- 资助金额:
$ 134.82万 - 项目类别:
Gut microbiome, enteric infections and child growth across a rurual urban gradient
农村城市梯度中的肠道微生物组、肠道感染和儿童生长
- 批准号:
10190627 - 财政年份:2018
- 资助金额:
$ 134.82万 - 项目类别:
Gut microbiome, enteric infections and child growth across a rural urban gradient
城乡梯度的肠道微生物组、肠道感染和儿童生长
- 批准号:
9974179 - 财政年份:2018
- 资助金额:
$ 134.82万 - 项目类别:
Gut microbiome, enteric infections and child growth across a rurual urban gradient
农村城市梯度中的肠道微生物组、肠道感染和儿童生长
- 批准号:
10541904 - 财政年份:2018
- 资助金额:
$ 134.82万 - 项目类别:
Modeling the Effects of the Environment on Enteric Pathogen Dynamics
模拟环境对肠道病原体动力学的影响
- 批准号:
9474895 - 财政年份:2014
- 资助金额:
$ 134.82万 - 项目类别:
Modeling the Effects of the Environment on Enteric Pathogen Dynamics
模拟环境对肠道病原体动态的影响
- 批准号:
8703237 - 财政年份:2014
- 资助金额:
$ 134.82万 - 项目类别:
Modeling the Effects of the Environment on Enteric Pathogen Dynamics
模拟环境对肠道病原体动态的影响
- 批准号:
9098766 - 财政年份:2014
- 资助金额:
$ 134.82万 - 项目类别:
相似国自然基金
猪急性腹泻综合征冠状病毒(SADS-CoV)辅助蛋白NS7a/7b的离子通道活性及其调控细胞凋亡机制的研究
- 批准号:32302841
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型猪冠状病毒SADS-CoV入侵过程中S蛋白与受体识别机制的结构与功能研究
- 批准号:31900879
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
肠道致病菌核型分型及同源克隆鉴定研究
- 批准号:39470647
- 批准年份:1994
- 资助金额:6.0 万元
- 项目类别:面上项目
相似海外基金
Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease
小分子免疫调节剂治疗克罗恩病的临床前验证
- 批准号:
10600659 - 财政年份:2023
- 资助金额:
$ 134.82万 - 项目类别:
Determining the Incidence, Risk Factors and Biological Drivers of Irritable Bowel Syndrome (IBS) as Part of the Constellation of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Outcomes
确定肠易激综合症 (IBS) 的发病率、危险因素和生物驱动因素作为 SARS-CoV-2 感染急性后遗症 (PASC) 结果的一部分
- 批准号:
10630409 - 财政年份:2023
- 资助金额:
$ 134.82万 - 项目类别:
Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines
基于轮状病毒的产肠毒素大肠杆菌双重疫苗的研制
- 批准号:
10741541 - 财政年份:2023
- 资助金额:
$ 134.82万 - 项目类别:
Next generation ORS: Randomized controlled trial comparing ORS with calcium vs standard ORS in reducing severity of adults with acute watery diarrhea
下一代 ORS:比较 ORS 加钙与标准 ORS 在降低成人急性水样腹泻严重程度方面的随机对照试验
- 批准号:
10593311 - 财政年份:2023
- 资助金额:
$ 134.82万 - 项目类别:
GABAergic alterations in the BNST to VTA circuit following morphine withdrawal
吗啡戒断后 BNST 至 VTA 回路的 GABA 能变化
- 批准号:
10607287 - 财政年份:2023
- 资助金额:
$ 134.82万 - 项目类别: